Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Joining forces for immune research

13.08.2018

The initiative “Immunology & Inflammation” unifies efforts in immunological research within the Helmholtz Association. 23 working groups from five Helmholtz Centers are joining forces to address some of the most complex problems in today's immunology in ways that can only be explored in collaboration.

“What we have learned about the immune system and its role in many widespread diseases over the last ten years opens up countless perspectives for research," says Professor Martin Lohse, Scientific Director of the Max Delbrück Center for Molecular Medicine (MDC), the center that coordinates the initiative.


“Our initiative's projects combine the centers’ research topics,” says Professor Pierluigi Nicotera, Vice-President of the Helmholtz Association and Coordinator of the Field of Health Research. “They address key questions such as: How do the immune and nervous systems interact? How does the microenvironment of tissue influence the development of immune cells and what consequences does it have for cancer? How do we use this knowledge for therapies?”

Scientists working in more than 20 projects address these and other questions. Six of those are designed as tandem projects, which are special cooperative ventures involving teams from different centers. Additionally, researchers will meet and exchange knowledge in regularly. The first “Immunology & Inflammation” Conference will take place 24th-26th February 2019 in Berlin, and will host world-leading scientists as speakers.

Curing congenital immune deficiencies with CRISPR-Cas9

One of the six tandem projects, for example, brings together the teams of Professor Mathias Heikenwälder (DKFZ) and Dr. Uta Höpken (MDC) to investigate the influence of inflammatory processes and signaling molecules on the spread of blood cancer. Patients with lymphoma metastases have significantly reduced chances of survival. How and why lymphomas implant themselves in other organs such as the liver or brain is yet unknown.

Another joint project, led by Professor Klaus Rajewsky (MDC) and Professor Ellen Renner (HMGU), explores gene therapy using the CRISPR-Cas9 gene editing toolkit. The aim of this project is to open up an avenue for curing rare congenital immunodeficiencies such as Job´s syndrome, in which only a single gene is mutated.

A total of 23 working groups from five Helmholtz Centers are participating in this initiative, headed by Professor Klaus Rajewsky and Professor Michela Di Virgilio (MDC). They say: “The centers have a broad repertoire of state-of-the-art technologies and expertise. Our joint initiative provides a strong impulse to their work, both in terms of basic research and the development of new therapies.”

Organization and financing

The initiative brings together immunological research distributed among five centers of the Helmholtz Association in the research field health in a common structure. The involved Helmholtz Centers are:

Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin (coordinating center),
German Cancer Research Center (DKFZ), Heidelberg,
German Center for Neurodegenerative Diseases (DZNE), Bonn,
Helmholtz Zentrum München (HMGU), Munich, and
Helmholtz Centre for Infection Research (HZI), Braunschweig.

The three-year initiative started in November 2017, and it is the nucleus for a long-term research program that will position the Helmholtz Association internationally as a major player in application-oriented immunology research.

The Helmholtz Association is supporting the initiative through the Initiative and Networking Fund (Zukunftsthemen) with five million euros. The individual centers contribute the same amount from their own budget.

Wissenschaftliche Ansprechpartner:

Marta González Gómez
Project Coordinator “Immunologie & Inflammation”
Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)
Marta.GonzalezGomez@mdc-berlin.de
+49 30 9406-4268

Professor Michela Di Virgilio
Project leader “Immunologie & Inflammation”
Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)
Michela.DiVirgilio@mdc-berlin.de

Professor Klaus Rajewsky
Project Leader “Immunologie & Inflammation”
Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)
Klaus.Rajewsky@mdc-berlin.de

Weitere Informationen:

https://www.mdc-berlin.de/immunology – Website “Immunology & Inflammation”, including a list of participating Helmholtz Research Centers and more detailed descriptions

Annette Tuffs | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft
Further information:
http://www.mdc-berlin.de/

More articles from Life Sciences:

nachricht Platinum nanoparticles for selective treatment of liver cancer cells
15.02.2019 | ETH Zurich

nachricht New molecular blueprint advances our understanding of photosynthesis
15.02.2019 | DOE/Lawrence Berkeley National Laboratory

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Regensburg physicists watch electron transfer in a single molecule

For the first time, an international team of scientists based in Regensburg, Germany, has recorded the orbitals of single molecules in different charge states in a novel type of microscopy. The research findings are published under the title “Mapping orbital changes upon electron transfer with tunneling microscopy on insulators” in the prestigious journal “Nature”.

The building blocks of matter surrounding us are atoms and molecules. The properties of that matter, however, are often not set by these building blocks...

Im Focus: University of Konstanz gains new insights into the recent development of the human immune system

Scientists at the University of Konstanz identify fierce competition between the human immune system and bacterial pathogens

Cell biologists from the University of Konstanz shed light on a recent evolutionary process in the human immune system and publish their findings in the...

Im Focus: Transformation through Light

Laser physicists have taken snapshots of carbon molecules C₆₀ showing how they transform in intense infrared light

When carbon molecules C₆₀ are exposed to an intense infrared light, they change their ball-like structure to a more elongated version. This has now been...

Im Focus: Famous “sandpile model” shown to move like a traveling sand dune

Researchers at IST Austria find new property of important physical model. Results published in PNAS

The so-called Abelian sandpile model has been studied by scientists for more than 30 years to better understand a physical phenomenon called self-organized...

Im Focus: Cryo-force spectroscopy reveals the mechanical properties of DNA components

Physicists from the University of Basel have developed a new method to examine the elasticity and binding properties of DNA molecules on a surface at extremely low temperatures. With a combination of cryo-force spectroscopy and computer simulations, they were able to show that DNA molecules behave like a chain of small coil springs. The researchers reported their findings in Nature Communications.

DNA is not only a popular research topic because it contains the blueprint for life – it can also be used to produce tiny components for technical applications.

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Global Legal Hackathon at HAW Hamburg

11.02.2019 | Event News

The world of quantum chemistry meets in Heidelberg

30.01.2019 | Event News

Our digital society in 2040

16.01.2019 | Event News

 
Latest News

Gravitational waves will settle cosmic conundrum

15.02.2019 | Physics and Astronomy

Spintronics by 'straintronics'

15.02.2019 | Physics and Astronomy

Platinum nanoparticles for selective treatment of liver cancer cells

15.02.2019 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>